Elite Pharmaceuticals (ELTP) Asset Utilization Ratio (2011 - 2026)
Elite Pharmaceuticals' Asset Utilization Ratio was 1.01 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 0.1% from 1.02 a year earlier and down 9.8% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Asset Utilization Ratio at Elite Pharmaceuticals came in at 1.27, up 35.9% from FY2025.
- Asset Utilization Ratio has now increased for three consecutive fiscal years.
- In earlier fiscal years, Asset Utilization Ratio was 0.93 in FY2025 (+2.7%), 0.91 in FY2024 (+1.2%), 0.90 in FY2023 (-14.6%) and 1.05 in FY2022 (+6.0%).
- The fiscal Q1 2027 figure marks the lowest quarterly Asset Utilization Ratio since fiscal Q4 2025.
- Compared with a year earlier, Asset Utilization Ratio was higher in seven of the last eight quarters, with growth averaging 24.7%.
- The best year-over-year quarter for Asset Utilization Ratio over five years was fiscal Q3 2026 (growth of 47.0%); the worst was fiscal Q3 2023 (a decline of 30.5%).
- Per Business Quant data, ELTP's Asset Utilization Ratio in the three fiscal quarters before Q1 2027 was 1.12 (Q4 2026), 1.15 (Q3 2026) and 1.08 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 0.31 |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 1.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 |
| Mar 31, 2026 | 1.12 |
| Dec 31, 2025 | 1.15 |
| Sep 30, 2025 | 1.08 |
| Jun 30, 2025 | 1.02 |
| Mar 31, 2025 | 0.90 |
| Dec 31, 2024 | 0.78 |
| Sep 30, 2024 | 0.81 |
| Jun 30, 2024 | 0.77 |
| Mar 31, 2024 | 0.72 |
| Dec 31, 2023 | 0.65 |
| Sep 30, 2023 | 0.70 |
| Jun 30, 2023 | 0.81 |
| Mar 31, 2023 | 0.73 |
| Dec 31, 2022 | 0.64 |
| Mar 31, 2022 | 0.96 |
| Dec 31, 2021 | 0.93 |
| Sep 30, 2021 | 0.86 |
| Jun 30, 2021 | 0.89 |
| Mar 31, 2021 | 0.93 |
API Access
Elite Pharmaceuticals Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();